Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Changes in the neutrophil-to-lymphocyte ratio predict the prognosis of patients with advanced hepatocellular carcinoma treated with sorafenib.

Hong YM, Yoon KT, Hwang TH, Heo J, Woo HY, Cho M.

Eur J Gastroenterol Hepatol. 2019 Mar 28. doi: 10.1097/MEG.0000000000001405. [Epub ahead of print]

PMID:
30925530
2.

Dual Mode Gait Sonification for Rehabilitation After Unilateral Hip Arthroplasty.

Reh J, Hwang TH, Schmitz G, Effenberg AO.

Brain Sci. 2019 Mar 19;9(3). pii: E66. doi: 10.3390/brainsci9030066.

3.

10-Phenyltriazoyl Artemisinin is a Novel P-glycoprotein Inhibitor that Suppresses the Overexpression and Function of P-glycoprotein.

Lee DH, Hasanuzzaman M, Kwon D, Choi HY, Kim SM, Kim DJ, Kang DJ, Hwang TH, Kim HH, Shin HJ, Shin JG, Oh S, Lee S, Kim SW.

Curr Pharm Des. 2018;24(46):5590-5597. doi: 10.2174/1381612825666190222155700.

PMID:
30799787
4.

Training proprioception with sound: effects of real-time auditory feedback on intermodal learning.

Ghai S, Schmitz G, Hwang TH, Effenberg AO.

Ann N Y Acad Sci. 2019 Feb;1438(1):50-61. doi: 10.1111/nyas.13967. Epub 2018 Sep 17.

PMID:
30221775
5.

Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus.

Cho E, Ryu EJ, Jiang F, Jeon UB, Cho M, Kim CH, Kim M, Kim ND, Hwang TH.

Drug Des Devel Ther. 2018 Aug 8;12:2467-2474. doi: 10.2147/DDDT.S171269. eCollection 2018.

6.

HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer.

Alyamani M, Emamekhoo H, Park S, Taylor J, Almassi N, Upadhyay S, Tyler A, Berk MP, Hu B, Hwang TH, Figg WD, Peer CJ, Chien C, Koshkin VS, Mendiratta P, Grivas P, Rini B, Garcia J, Auchus RJ, Sharifi N.

J Clin Invest. 2018 Aug 1;128(8):3333-3340. doi: 10.1172/JCI98319. Epub 2018 Jun 25.

7.

Movement Sonification in Stroke Rehabilitation.

Schmitz G, Bergmann J, Effenberg AO, Krewer C, Hwang TH, Müller F.

Front Neurol. 2018 Jun 1;9:389. doi: 10.3389/fneur.2018.00389. eCollection 2018.

8.

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.

McMillan EA, Ryu MJ, Diep CH, Mendiratta S, Clemenceau JR, Vaden RM, Kim JH, Motoyaji T, Covington KR, Peyton M, Huffman K, Wu X, Girard L, Sung Y, Chen PH, Mallipeddi PL, Lee JY, Hanson J, Voruganti S, Yu Y, Park S, Sudderth J, DeSevo C, Muzny DM, Doddapaneni H, Gazdar A, Gibbs RA, Hwang TH, Heymach JV, Wistuba I, Coombes KR, Williams NS, Wheeler DA, MacMillan JB, Deberardinis RJ, Roth MG, Posner BA, Minna JD, Kim HS, White MA.

Cell. 2018 May 3;173(4):864-878.e29. doi: 10.1016/j.cell.2018.03.028. Epub 2018 Apr 19.

9.

Effect- and Performance-Based Auditory Feedback on Interpersonal Coordination.

Hwang TH, Schmitz G, Klemmt K, Brinkop L, Ghai S, Stoica M, Maye A, Blume H, Effenberg AO.

Front Psychol. 2018 Mar 29;9:404. doi: 10.3389/fpsyg.2018.00404. eCollection 2018.

10.
11.

Auditory Proprioceptive Integration: Effects of Real-Time Kinematic Auditory Feedback on Knee Proprioception.

Ghai S, Schmitz G, Hwang TH, Effenberg AO.

Front Neurosci. 2018 Mar 8;12:142. doi: 10.3389/fnins.2018.00142. eCollection 2018.

12.

Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.

Sun X, Wang SC, Wei Y, Luo X, Jia Y, Li L, Gopal P, Zhu M, Nassour I, Chuang JC, Maples T, Celen C, Nguyen LH, Wu L, Fu S, Li W, Hui L, Tian F, Ji Y, Zhang S, Sorouri M, Hwang TH, Letzig L, James L, Wang Z, Yopp AC, Singal AG, Zhu H.

Cancer Cell. 2018 Jan 8;33(1):151-152. doi: 10.1016/j.ccell.2017.12.011. No abstract available.

13.

Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.

Sun X, Wang SC, Wei Y, Luo X, Jia Y, Li L, Gopal P, Zhu M, Nassour I, Chuang JC, Maples T, Celen C, Nguyen LH, Wu L, Fu S, Li W, Hui L, Tian F, Ji Y, Zhang S, Sorouri M, Hwang TH, Letzig L, James L, Wang Z, Yopp AC, Singal AG, Zhu H.

Cancer Cell. 2017 Nov 13;32(5):574-589.e6. doi: 10.1016/j.ccell.2017.10.007. Erratum in: Cancer Cell. 2018 Jan 8;33(1):151-152.

14.

Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.

Aguilera KY, Huang H, Du W, Hagopian MM, Wang Z, Hinz S, Hwang TH, Wang H, Fleming JB, Castrillon DH, Ren X, Ding K, Brekken RA.

Mol Cancer Ther. 2017 Nov;16(11):2473-2485. doi: 10.1158/1535-7163.MCT-16-0834. Epub 2017 Sep 1.

15.

Bioinformatics Data Analysis of Next-Generation Sequencing Data from Heterogeneous Tumor Samples.

Landman SR, Hwang TH.

Methods Mol Biol. 2017;1633:185-192. doi: 10.1007/978-1-4939-7142-8_12.

PMID:
28735488
16.

Purine synthesis promotes maintenance of brain tumor initiating cells in glioma.

Wang X, Yang K, Xie Q, Wu Q, Mack SC, Shi Y, Kim LJY, Prager BC, Flavahan WA, Liu X, Singer M, Hubert CG, Miller TE, Zhou W, Huang Z, Fang X, Regev A, Suvà ML, Hwang TH, Locasale JW, Bao S, Rich JN.

Nat Neurosci. 2017 May;20(5):661-673. doi: 10.1038/nn.4537. Epub 2017 Mar 27.

17.

Delicate Structural Control of Si-SiOx-C Composite via High-Speed Spray Pyrolysis for Li-Ion Battery Anodes.

Lee SJ, Kim HJ, Hwang TH, Choi S, Park SH, Deniz E, Jung DS, Choi JW.

Nano Lett. 2017 Mar 8;17(3):1870-1876. doi: 10.1021/acs.nanolett.6b05191. Epub 2017 Feb 16.

PMID:
28191851
18.

Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment.

Lee NH, Kim M, Oh SY, Kim SG, Kwon HC, Hwang TH.

Oncotarget. 2017 Jan 3;8(1):1213-1225. doi: 10.18632/oncotarget.13598.

19.

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.

Henzler C, Li Y, Yang R, McBride T, Ho Y, Sprenger C, Liu G, Coleman I, Lakely B, Li R, Ma S, Landman SR, Kumar V, Hwang TH, Raj GV, Higano CS, Morrissey C, Nelson PS, Plymate SR, Dehm SM.

Nat Commun. 2016 Nov 29;7:13668. doi: 10.1038/ncomms13668.

20.

PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

Zhou X, Updegraff BL, Guo Y, Peyton M, Girard L, Larsen JE, Xie XJ, Zhou Y, Hwang TH, Xie Y, Rodriguez-Canales J, Villalobos P, Behrens C, Wistuba II, Minna JD, O'Donnell KA.

Cancer Res. 2017 Jan 1;77(1):187-197. doi: 10.1158/0008-5472.CAN-16-1267-T. Epub 2016 Nov 7.

21.

Targeting renal cell carcinoma with a HIF-2 antagonist.

Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, Zhang H, Chang J, Gardner KH, Bruick RK, Reeves C, Hwang TH, Courtney K, Frenkel E, Sun X, Zojwalla N, Wong T, Rizzi JP, Wallace EM, Josey JA, Xie Y, Xie XJ, Kapur P, McKay RM, Brugarolas J.

Nature. 2016 Nov 3;539(7627):112-117. doi: 10.1038/nature19796. Epub 2016 Sep 5.

22.

Transfer learning across ontologies for phenome-genome association prediction.

Petegrosso R, Park S, Hwang TH, Kuang R.

Bioinformatics. 2017 Feb 15;33(4):529-536. doi: 10.1093/bioinformatics/btw649.

PMID:
27797759
23.

A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma.

Chen KS, Kwon WS, Kim J, Heo SJ, Kim HS, Kim HK, Kim SH, Lee WS, Chung HC, Rha SY, Hwang TH.

Cold Spring Harb Mol Case Stud. 2016 Sep;2(5):a000992. doi: 10.1101/mcs.a000992.

24.

Integrated omics-analysis reveals Wnt-mediated NAD+ metabolic reprogramming in cancer stem-like cells.

Lee J, Kee HJ, Min S, Park KC, Park S, Hwang TH, Ryu DH, Hwang GS, Cheong JH.

Oncotarget. 2016 Jul 26;7(30):48562-48576. doi: 10.18632/oncotarget.10432.

25.

Seasonal Patterns of Asthma in Children and Adolescents Presenting at Emergency Departments in Korea.

Won YK, Hwang TH, Roh EJ, Chung EH.

Allergy Asthma Immunol Res. 2016 May;8(3):223-9. doi: 10.4168/aair.2016.8.3.223.

26.

Elemental-Sulfur-Mediated Facile Synthesis of a Covalent Triazine Framework for High-Performance Lithium-Sulfur Batteries.

Talapaneni SN, Hwang TH, Je SH, Buyukcakir O, Choi JW, Coskun A.

Angew Chem Int Ed Engl. 2016 Feb 24;55(9):3106-11. doi: 10.1002/anie.201511553. Epub 2016 Jan 28.

PMID:
26822950
27.

Comprehensive Ex Vivo Transposon Mutagenesis Identifies Genes That Promote Growth Factor Independence and Leukemogenesis.

Guo Y, Updegraff BL, Park S, Durakoglugil D, Cruz VH, Maddux S, Hwang TH, O'Donnell KA.

Cancer Res. 2016 Feb 15;76(4):773-86. doi: 10.1158/0008-5472.CAN-15-1697. Epub 2015 Dec 16.

28.

An integrative somatic mutation analysis to identify pathways linked with survival outcomes across 19 cancer types.

Park S, Kim SJ, Yu D, Peña-Llopis S, Gao J, Park JS, Chen B, Norris J, Wang X, Chen M, Kim M, Yong J, Wardak Z, Choe K, Story M, Starr T, Cheong JH, Hwang TH.

Bioinformatics. 2016 Jun 1;32(11):1643-51. doi: 10.1093/bioinformatics/btv692. Epub 2015 Dec 3.

29.

Membrane-reinforced three-dimensional electrospun silk fibroin scaffolds for bone tissue engineering.

Yang SY, Hwang TH, Che L, Oh JS, Ha Y, Ryu W.

Biomed Mater. 2015 Jun 24;10(3):035011. doi: 10.1088/1748-6041/10/3/035011.

PMID:
26106926
30.

mRNA 3'-UTR shortening is a molecular signature of mTORC1 activation.

Chang JW, Zhang W, Yeh HS, de Jong EP, Jun S, Kim KH, Bae SS, Beckman K, Hwang TH, Kim KS, Kim DH, Griffin TJ, Kuang R, Yong J.

Nat Commun. 2015 Jun 15;6:7218. doi: 10.1038/ncomms8218.

PMID:
26074333
31.

Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer.

Park SH, Breitbach CJ, Lee J, Park JO, Lim HY, Kang WK, Moon A, Mun JH, Sommermann EM, Maruri Avidal L, Patt R, Pelusio A, Burke J, Hwang TH, Kirn D, Park YS.

Mol Ther. 2015 Sep;23(9):1532-40. doi: 10.1038/mt.2015.109. Epub 2015 Jun 15.

32.

A Phase 2, Open-Label, Randomized Study of Pexa-Vec (JX-594) Administered by Intratumoral Injection in Patients with Unresectable Primary Hepatocellular Carcinoma.

Breitbach CJ, Moon A, Burke J, Hwang TH, Kirn DH.

Methods Mol Biol. 2015;1317:343-57. doi: 10.1007/978-1-4939-2727-2_19.

PMID:
26072416
33.

Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic.

Breitbach CJ, Parato K, Burke J, Hwang TH, Bell JC, Kirn DH.

Curr Opin Virol. 2015 Aug;13:49-54. doi: 10.1016/j.coviro.2015.03.016. Epub 2015 Apr 17. Review.

PMID:
25900822
34.

Intersection of DNA privacy and whole-genome sequencing.

Hong C, Wang J, Xing C, Hwang TH, Park JY.

Clin Chem. 2015 Jul;61(7):900-2. doi: 10.1373/clinchem.2014.235499. Epub 2015 Feb 5. No abstract available.

35.

The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594).

Breitbach CJ, Bell JC, Hwang TH, Kirn DH, Burke J.

Oncolytic Virother. 2015 Jan 28;4:25-31. doi: 10.2147/OV.S59640. eCollection 2015. Review.

36.

Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients.

Cripe TP, Ngo MC, Geller JI, Louis CU, Currier MA, Racadio JM, Towbin AJ, Rooney CM, Pelusio A, Moon A, Hwang TH, Burke JM, Bell JC, Kirn DH, Breitbach CJ.

Mol Ther. 2015 Mar;23(3):602-8. doi: 10.1038/mt.2014.243. Epub 2014 Dec 22.

37.

First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.

Zeh HJ, Downs-Canner S, McCart JA, Guo ZS, Rao UN, Ramalingam L, Thorne SH, Jones HL, Kalinski P, Wieckowski E, O'Malley ME, Daneshmand M, Hu K, Bell JC, Hwang TH, Moon A, Breitbach CJ, Kirn DH, Bartlett DL.

Mol Ther. 2015 Jan;23(1):202-14. doi: 10.1038/mt.2014.194. Epub 2014 Oct 8.

38.

Hierarchical porous carbon by ultrasonic spray pyrolysis yields stable cycling in lithium-sulfur battery.

Jung DS, Hwang TH, Lee JH, Koo HY, Shakoor RA, Kahraman R, Jo YN, Park MS, Choi JW.

Nano Lett. 2014 Aug 13;14(8):4418-25. doi: 10.1021/nl501383g. Epub 2014 Jul 14.

PMID:
25007002
39.

SHEAR: sample heterogeneity estimation and assembly by reference.

Landman SR, Hwang TH, Silverstein KA, Li Y, Dehm SM, Steinbach M, Kumar V.

BMC Genomics. 2014 Jan 29;15:84. doi: 10.1186/1471-2164-15-84.

40.

Review of biological network data and its applications.

Yu D, Kim M, Xiao G, Hwang TH.

Genomics Inform. 2013 Dec;11(4):200-10. doi: 10.5808/GI.2013.11.4.200. Epub 2013 Dec 31. Review.

41.

Thrombus aspiration during primary percutaneous coronary intervention for preserving the index of microcirculatory resistance: a randomised study.

Woo SI, Park SD, Kim DH, Kwan J, Shin SH, Park KS, Kim SH, Ko KY, Hwang TH, Yoon GS, Choi WG, Kim SH.

EuroIntervention. 2014 Jan 22;9(9):1057-62. doi: 10.4244/EIJV9I9A179.

42.

TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.

Nyquist MD, Li Y, Hwang TH, Manlove LS, Vessella RL, Silverstein KA, Voytas DF, Dehm SM.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17492-7. doi: 10.1073/pnas.1308587110. Epub 2013 Oct 7.

43.

One-dimensional carbon-sulfur composite fibers for Na-S rechargeable batteries operating at room temperature.

Hwang TH, Jung DS, Kim JS, Kim BG, Choi JW.

Nano Lett. 2013 Sep 11;13(9):4532-8. doi: 10.1021/nl402513x. Epub 2013 Sep 3.

PMID:
23981085
44.

Large-scale integrative network-based analysis identifies common pathways disrupted by copy number alterations across cancers.

Hwang TH, Atluri G, Kuang R, Kumar V, Starr T, Silverstein KA, Haverty PM, Zhang Z, Liu J.

BMC Genomics. 2013 Jul 3;14:440. doi: 10.1186/1471-2164-14-440.

45.

A fully integrated sensor SoC with digital calibration hardware and wireless transceiver at 2.4 GHz.

Kim DS, Jang SJ, Hwang TH.

Sensors (Basel). 2013 May 21;13(5):6775-92. doi: 10.3390/s130506775.

46.

Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans.

Kim MK, Breitbach CJ, Moon A, Heo J, Lee YK, Cho M, Lee JW, Kim SG, Kang DH, Bell JC, Park BH, Kirn DH, Hwang TH.

Sci Transl Med. 2013 May 15;5(185):185ra63. doi: 10.1126/scitranslmed.3005361.

47.

Spray drying method for large-scale and high-performance silicon negative electrodes in Li-ion batteries.

Jung DS, Hwang TH, Park SB, Choi JW.

Nano Lett. 2013 May 8;13(5):2092-7. doi: 10.1021/nl400437f. Epub 2013 Apr 5.

PMID:
23537321
48.

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.

Heo J, Reid T, Ruo L, Breitbach CJ, Rose S, Bloomston M, Cho M, Lim HY, Chung HC, Kim CW, Burke J, Lencioni R, Hickman T, Moon A, Lee YS, Kim MK, Daneshmand M, Dubois K, Longpre L, Ngo M, Rooney C, Bell JC, Rhee BG, Patt R, Hwang TH, Kirn DH.

Nat Med. 2013 Mar;19(3):329-36. doi: 10.1038/nm.3089. Epub 2013 Feb 10.

49.

Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.

Breitbach CJ, Arulanandam R, De Silva N, Thorne SH, Patt R, Daneshmand M, Moon A, Ilkow C, Burke J, Hwang TH, Heo J, Cho M, Chen H, Angarita FA, Addison C, McCart JA, Bell JC, Kirn DH.

Cancer Res. 2013 Feb 15;73(4):1265-75. doi: 10.1158/0008-5472.CAN-12-2687. Epub 2013 Feb 7.

50.

Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells.

Park SN, Noh KT, Jeong YI, Jung ID, Kang HK, Cha GS, Lee SJ, Seo JK, Kang DH, Hwang TH, Lee EK, Kwon B, Park YM.

Exp Mol Med. 2013 Feb 8;45:e8. doi: 10.1038/emm.2013.14.

Supplemental Content

Loading ...
Support Center